CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-23 | Biller Scott Chief Scientific Officer | Grant or award · Stock option (right to buy) | +12,363 | 314,880 | ||
| 2015-06-18 | NELSEN ROBERT Director | Other disposition | −386,074 | 1,630,368 | ||
| 2015-06-18 | NELSEN ROBERT Director | Other acquisition | +19,622 | 47,666 | ||
| 2015-06-17 | NELSEN ROBERT Director | Other disposition | −386,074 | 2,016,442 | ||
| 2015-06-17 | NELSEN ROBERT Director | Other acquisition | +19,622 | 28,044 | ||
| 2015-06-16 | Biller Scott Chief Scientific Officer | Exercise or conversion | +300 | $0.47 | $140 | 37,570 |
| 2015-06-16 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −300 | 302,517 | ||
| 2015-06-15 | MARAGANORE JOHN Director | Gift | −410 | 49,764 | ||
| 2015-06-15 | Higgons John Duncan Chief Operating Officer | Sale | −7,000 | $105.23 | $737K | 121,835 |
| 2015-06-12 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 128,835 |
| 2015-06-12 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 335,022 | ||
| 2015-06-11 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 118,835 |
| 2015-06-11 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 345,022 | ||
| 2015-06-10 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 108,835 |
| 2015-06-10 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 355,022 | ||
| 2015-06-08 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $121.85 | $670K | 37,270 |
| 2015-06-01 | Schenkein David P Chief Executive Officer | Sale | −6,500 | $120.67 | $784K | 79,082 |
| 2015-06-01 | Schenkein David P Chief Executive Officer | Sale | −6,500 | $120.67 | $784K | 232,272 |
| 2015-06-01 | Bowden Christopher Chief Medical Officer | Exercise or conversion | +5,000 | $35.16 | $176K | 5,000 |
| 2015-06-01 | Bowden Christopher Chief Medical Officer | Sale | −5,000 | $120.67 | $603K | 0 |
Page 90 of 93 · 1,853 trades